Viewing StudyNCT01055522



Ignite Creation Date: 2024-05-05 @ 10:12 PM
Last Modification Date: 2024-10-26 @ 10:15 AM
Study NCT ID: NCT01055522
Status: TERMINATED
Last Update Posted: 2014-02-25
First Post: 2010-01-22

Brief Title: Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma
Sponsor: Philogen SpA
Organization: Philogen SpA

Conditions & Keywords Data

Conditions:
Name
Metastatic Melanoma
Keywords:
Name View
L19 View
Interleukin IL2 monoclonal antibody cytokine Dacarbazine metastatic melanoma tumor targeting Dose definition View